Clinical Trial Update: Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the efficacy and safety of an anti-adhesion product to prevent intraperitoneal adhesions; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraperitoneal Adhesions

Drugs mentioned

• Anti-Adhesion Product

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Intraperitoneal Adhesions | Phase 2 | Status: COMPLETED